UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000040857
Receipt number R000046651
Scientific Title Efficacy of metformin 1000mg once or twice daily in patients with type 2 diabetes
Date of disclosure of the study information 2020/07/01
Last modified on 2022/11/28 18:16:39

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of metformin 1000mg once or twice daily in patients with type 2 diabetes

Acronym

Efficacy of metformin 1000 mg once or twice daily

Scientific Title

Efficacy of metformin 1000mg once or twice daily in patients with type 2 diabetes

Scientific Title:Acronym

Efficacy of metformin 1000 mg once or twice daily

Region

Japan


Condition

Condition

Type 2 diabetes

Classification by specialty

Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We examine the difference in efficacy depending on the administration method of metformin 1000 mg/day.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

24-hour average blood glucose, fasting blood glucose, SD and CV.

Key secondary outcomes

TIR(time in range), TAR(time above range), TBR(time below range), MAGE(mean amplitude of glucose excursion), maximum blood glucose level, minimum blood glucose level and safety.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

We evaluate glycemic dynamics for 14 days with flash glucose monitoring (FGM) in patients with type 2 diabetes receiving 1000 mg/day of metformin.
First half of observation period (Day 1-7): Metformin 1000 mg orally twice daily (after morning and dinner).
Late observation period (Day 8-14): Metformin 1000 mg orally once daily (after breakfast).

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

Type 2 diabetes
Administration of metformin 1000 mg/day
eGFR 45ml/min/1.73m2<=

Key exclusion criteria

1. Patients with a history of hypersensitivity to metformin components or biguanide drugs
2. Patients with a history of lactic acidosis
3. Patients with severe renal dysfunction or dialysis patients
4. Patients with severe liver dysfunction
5. Patients with severely impaired cardiovascular system or pulmonary function and other patients who are prone to hypoxemia
6. Patients with dehydration or suspected dehydration
7. Excessive alcohol drinkers
8. Patients with severe ketosis, diabetic coma or pre-coma, or type 1 diabetes
9. Patients with severe infection, before and after surgery, and serious trauma
10. Patients with malnutrition, starvation, weakness, pituitary dysfunction, or adrenal insufficiency
11. Pregnant women, women who may be pregnant, or women who are breast-feeding
12.Other cases judged by the investigator to be inappropriate for this study

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Tetsuo
Middle name
Last name Hayakawa

Organization

Tonami general hospital

Division name

Department of diabetes mellitus and endocrinology

Zip code

939-1395

Address

1-61 Shintomi-cho, Tonami, Toyama, 939-1395, Japan

TEL

0763-32-3320

Email

thayakawa-endo@umin.ac.jp


Public contact

Name of contact person

1st name Ken-ichiro
Middle name
Last name Kato

Organization

Tonami general hospital

Division name

Department of diabetes mellitus and endocrinology

Zip code

939-1395

Address

1-61 Shintomi-cho, Tonami, Toyama, 939-1395, Japan

TEL

0763-32-3320

Homepage URL


Email

katou-knz@umin.ac.jp


Sponsor or person

Institute

Tonami general hospital
Department of diabetes mellitus and endocrinology

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization

None


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tonami general hospital Ethics Committee

Address

1-61 Shintomi-cho, Tonami, Toyama, 939-1395, Japan

Tel

0763-32-3320

Email

thayakawa-endo@umin.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

0

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2020 Year 06 Month 01 Day

Date of IRB

2020 Year 06 Month 16 Day

Anticipated trial start date

2020 Year 07 Month 01 Day

Last follow-up date

2025 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 06 Month 22 Day

Last modified on

2022 Year 11 Month 28 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046651


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name